54 Annual Report 2021 PRINCIPLE A: BOARD LEADERSHIP AND EFFECTIVENESS (CONT’D) II. BOARD COMPOSITION (CONT’D) 5. Nomination Committee (Cont’d) (vi) identified suitable training programmes for the Directors and Audit Committee; and (vii) deliberated on the findings of the assessments and reported the findings to the Board. T he terms of reference of the Nomination Committee are available for reference at www.mkhberhad.com. 6. Board and Board Committee Evaluation The Nomination Committee also assesses the effectiveness of the Board as a whole and Audit Committee and the contribution of each individual Director, including Independent Non-Executive Directors on an annual basis. The evaluation process was led by the Nomination Committee’s Chairman and supported by the Company Secretary. The evaluation results were considered by the Nomination Committee, which then made recommendations to the Board with the aim of helping the Board to discharge its duties and responsibilities. The evaluation was based on specific criteria such as Board composition and structure, principal responsibilities of the Board, the Board process and Board governance. T he Nomination Committee conducted the Board members performance evaluation via questionnaires which covers Board’s effectiveness as a whole together with Directors’ self-assessment. The Directors’ self-assessment was conducted to evaluate the mix of skills, experience and the individual Director’s ability to contribute and exercise independent judgement towards the effective functioning of the Board. The Nomination Committee also conducted the review of the Audit Committee members’ performance via questionnaire and self and peer evaluation form to ensure a balanced and objective review by the Directors and the Audit Committee for the abovementioned key areas. T he Nomination Committee also evaluates the independence of the Independent Non-Executive Directors based on the criteria of “Independence” as prescribed in the MMLR of Bursa Securities. D uring the deliberation of the performance of an individual Director who is also a member of the Nomination Committee, that member will abstains from the deliberation of his or her own performance to avoid any conflict of interests. T he Nomination Committee, pursuant to the annual review that was carried out, was satisfied that the size of the Board is optimum, well-balanced with the appropriate mix of skills and experience for the composition of the Board and its Committees. All assessments and valuation carried out by the Nomination Committee in discharging its duties were also properly documented. Corporate Governance Overview Statement
RkJQdWJsaXNoZXIy NDgzMzc=